RxDoctor Payments Data

Byron Limmer, MD

MOHS-Micrographic Surgery · San Antonio, TXNPI 1407963796

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 47 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,121 and has fallen 55.1% since, to $503 in 2025.

$3,913in general payments, 2019–2025

Across 47 payments — averaging $83.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$556
  • AbbVie$449
  • Regeneron Healthcare Solutions, Inc.$368
  • Pfizer$282
  • Sun Pharmaceutical Industries Inc.$273
  • Janssen Scientific Affairs, LLC$250
  • plus $2K from 13 others

What the payments were for

  • Food & beverage$3,913100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,913 in reported general payments places this provider in the 65th percentile of 109 mohs-micrographic surgery providers in Texas.

See all mohs-micrographic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$599,984
Medicare patients
949
Services billed
7,177

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OtezlaApremilast11$50,851
Metronidazole35$1,992
Clobetasol Propionate45$1,850
Pimecrolimus12$1,567
Triamcinolone Acetonide100$1,465
Doxycycline Hyclate50$1,194
Fluorouracil15$1,150
Hydrocortisone34$537
Halobetasol Propionate13$474
Ketoconazole18$363
Cefdinir17$292
Mupirocin22$164
Acyclovir11$155
Cephalexin11$145

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →